Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Surrozen, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +5 vs. Q2 2025
- Shares held
- 6.34M
- +313.2K (+5.2%) vs. Q2 2025
- Total value
- $81.7M
- +$27.8M (+51.6%) vs. Q2 2025
- New holders
- 9
- 6 more added
- Sold out
- 4
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 2 | $26 | 0.00% | +2 | New |
| Bank of America Corp | 6 | $77 | 0.00% | −46−88.5% | Reduced |
| Barclays PLC | 13 | $168 | 0.00% | +13 | New |
| Wolverine Asset Management LLC | 281 | $3.62K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 1,000 | $12.9K | 0.00% | +1,000 | New |
| Alyeska Investment Group, L.P. | 10,188 | $131.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 13,326 | $171.7K | 0.00% | +13,326 | New |
| BlackRock, Inc. | 13,743 | $177.1K | 0.00% | −1,740−11.2% | Reduced |
| Citadel Advisors LLC | 13,875 | $178.8K | 0.00% | +3,424+32.8% | Added |
| Renaissance Technologies LLC | 14,726 | $189.7K | 0.00% | +100+0.7% | Added |
| Price T Rowe Associates Inc | 21,715 | $280.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 34,764 | $447.9K | 0.00% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 47,930 | $617.6K | 0.09% | 00.0% | Unchanged |
| Woodline Partners LP | 48,193 | $621.0K | 0.00% | +48,193 | New |
| Board of Trustees of The Leland Stanford Junior University | 52,130 | $671.7K | 0.08% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 54,527 | $702.9K | 0.00% | +23,564+76.1% | Added |
| ArrowMark Colorado Holdings LLC | 55,123 | $710.3K | 0.01% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 69,024 | $889.4K | 0.01% | +69,024 | New |
| Balyasny Asset Management LLC | 70,732 | $911.4K | 0.00% | +70,732 | New |
| Eversept Partners, LP | 76,997 | $992.1K | 0.08% | +76,997 | New |
| Euclidean Capital LLC | 87,696 | $1.13M | 0.47% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 88,653 | $1.14M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 109,769 | $1.41M | 0.00% | +109,769 | New |
| Regents of the University of California | 133,207 | $1.72M | 0.09% | 00.0% | Unchanged |
| Braidwell LP | 140,000 | $1.80M | 0.05% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 178,415 | $2.30M | 2.38% | +8,415+5.0% | Added |
| Nantahala Capital Management, LLC | 229,527 | $2.96M | 0.18% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 241,400 | $3.11M | 0.41% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 250,146 | $3.22M | 2.62% | −55,883−18.3% | Reduced |
| Vivo Capital, LLC | 260,000 | $3.35M | 0.27% | 00.0% | Unchanged |
| Vanguard Group Inc | 266,418 | $3.43M | 0.00% | +47,468+21.7% | Added |
| 5AM Venture Management, LLC | 310,000 | $3.99M | 1.46% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 602,626 | $7.76M | 0.10% | 00.0% | Unchanged |
| VR Adviser, LLC | 632,931 | $8.16M | 0.46% | 00.0% | Unchanged |
| StemPoint Capital LP | 713,463 | $9.19M | 1.85% | +26,924+3.9% | Added |
| The Column Group LLC | 1,499,773 | $19.3M | 23.88% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −67,566−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −259−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −216−100.0% | Sold out |